Sovato Secures Series B Funding to Advance Remote Robotic Surgery Platform

Sovato has closed a Series B funding round to scale its remote robotic surgery platform designed to enable physicians to perform procedures from a distance. The round was led by venture capital firm Beringea, with participation from Teladoc Health, GS Ventures, and the Laerdal Million Lives Fund. Following this latest investment, Sovato’s total funding now stands at $41 million.

The company’s system-agnostic platform supports surgical, interventional, and diagnostic robotic systems, offering flexibility for healthcare providers seeking to implement remote procedural capabilities. While Sovato’s technology has not yet undergone review by the U.S. Food and Drug Administration (FDA), it has already demonstrated promising preclinical results. In June 2024, the platform successfully facilitated a series of remote robotic-assisted surgery procedures across a 500-mile distance, highlighting its potential for long-distance surgical collaboration.

Sovato intends to use the new funding to advance product development, enhance regulatory readiness, and strengthen partnerships with surgical robotics manufacturers, healthcare providers, and related industry collaborators. The company views these efforts as essential to broadening access to surgical care and alleviating growing workforce constraints.

Cynthia Perazzo, co-founder and CEO of Sovato, emphasized the platform’s relevance in addressing global disparities in surgical access. “Over half the world’s population lacks access to timely, safe surgical care, and in the US, millions are still forced to travel for routine procedures – a challenge that will only grow as surgeon shortages intensify,” she said. Perazzo added, “Remote robotic surgery and procedure programmes provide healthcare organisations with a practical way to extend the reach and impact of skilled surgeons, care teams, and operating rooms, enabling a more sustainable and accessible model of care.”

The need for scalable surgical solutions continues to expand alongside projections of a significant surgeon shortfall in the United States — potentially nearing 20,000 by 2036. According to GlobalData, the global robotic surgical systems market is growing at a compound annual growth rate of 12.1% and is expected to reach $9.2 billion by 2034, up from $2.9 billion in 2024. Sovato’s platform aims to position the company at the forefront of this rapidly evolving sector by enabling remote, efficient, and equitable surgical care delivery.

Click here for the original news story.